Current challenges and future perspectives in Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis
As part of Novartis’ continued commitment to medical education in rheumatology. We Invite you to our faculty as they discuss:
-The disease state of JPsA and ERA and the impact of diagnosis, clinical features, and disease activity on patients and caregivers.
-The importance of both the patient perspective and the unmet needs for optimizing the management of JPsA and ERA
-Clinical evidence for IL17 inhibition in the management of ERA and JPsA.